John H. Klein v. Marc Wasserman

Court of Chancery of Delaware·Decided May 29, 2019·No. C.A. No. 2017-0643-KSJM·Published

Opinion

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE JOHN H. KLEIN and CAMBRIDGE ) THERAPEUTIC TECHNOLOGIES, ) LLC, )

)

Plaintiffs, )

)

v. ) C.A. No. 2017-0643-KSJM )

MARC WASSERMAN, ROBERT ) BRESLOW, and MONICA ) BRESLOW, )

)

Defendants. )

MEMORANDUM OPINION

Date Submitted: February 14, 2019 Date Decided: May 29, 2019

Michael F. Bonkowski, Andrew L. Cole, COLE SCHOTZ P.C., Wilmington, Delaware; Steven R. Klein, Rachel A. Mongiello, COLE SCHOTZ P.C., Hackensack, New Jersey; Counsel for Plaintiffs John H. Klein and Cambridge Therapeutic Technologies, LLC.

Lisa A. Schmidt, Matthew D. Perri, RICHARDS, LAYTON & FINGER, P.A., Wilmington, Delaware; Joseph L. Fogel, Michael P. Kornak, FREEBORN & PETERS LLP, Chicago, Illinois; Counsel for Defendants Marc Wasserman, Robert Breslow, and Monica Breslow.

McCORMICK, V.C.

In June 2016, defendants Monica and Robert Breslow invested $12.5 million in plaintiff Cambridge Therapeutic Technologies, LLC (“CTT”). The plaintiffs allege that after investing, the Breslows exhibited buyer’s remorse. They pressed for a buy-out of their equity stake and, to achieve this outcome, enlisted the aid of their board nominee, Marc Wasserman. According to the plaintiffs, through Wasserman, the Breslows embarked on a bad faith campaign to disrupt CTT’s operations as much as possible. Wasserman demanded that CTT allocate tax losses to the Breslows, circumvented protocol by requesting information directly from employees, threatened litigation to obtain that information, and interfered with CTT’s efforts to raise additional capital. The plaintiffs allege that Wasserman’s actions caused internal disruption, hostility, and instability, as well as delays in filing K-1 tax statements. To boot, CTT’s tax accountants and Chief Financial Officer resigned. But the Breslows never obtained a buy-out.

Instead, CTT’s founder John H. Klein caused CTT to commence this litigation. CTT alleges that Wasserman breached his fiduciary duty of loyalty by placing the Breslows’ interests ahead of the best interests of CTT and that the Breslows aided and abetted in Wasserman’s disloyal actions. CTT further alleges that the Breslows owed fiduciary duties as controllers of CTT, which they breached. In the alternative, CTT contends that the defendants breached the implied covenant of good faith and fair dealing inherent in CTT’s operating agreement.

The defendants have moved to dismiss the amended complaint, and this decision grants that motion as to the majority of the plaintiffs’ claims. Whittled down to size, the amended complaint states a claim for breach of fiduciary duty against Wasserman and for aiding and abetting against the Breslows. Wasserman owed a duty to advance the best interests of CTT. Under the plaintiff-friendly pleading standard, it is reasonably conceivable that Wasserman breached duties to CTT by engaging in a course of conduct to benefit the Breslows and harm CTT. Given the nature of Wasserman’s alleged acts, it is also reasonably conceivable that the Breslows knowingly participated in Wasserman’s actions.

The amended complaint, however, does not adequately allege facts sufficient to impose fiduciary duties on the Breslows as controllers. At bottom, the plaintiffs argue that the Breslows used their sources of influence—their board designee and his blocking rights under the operating agreement—to disrupt CTT’s operations to a level sufficient to force a buy-out. Some theories posit that chronic disruption could rise to the level of control. Take Trotskyism, for example. The allegations in this case do not support such a holding. The amended complaint itself describes the Breslows as on a “quest” for control, not wielding control. The Breslows never achieved their alleged goal. At best, CTT pleads that the Breslows successfully disrupted CTT, but not to a degree that would support a reasonable inference of control.

CTT’s claim for breach of the implied covenant of good faith and fair dealing likewise fails. Courts invoke the implied covenant to fill contractual gaps concerning developments that the parties did not anticipate. In this case, CTT identifies no gaps that require filling. The plaintiffs argue that the Breslows promised, before executing the operating agreement, to deliver certain clients to CTT. That alleged promise, however, was known and could have been expressly addressed in the agreement; it is not a promise the Court may enforce by implying terms now.

Klein is also a plaintiff in this case. After CTT commenced this litigation, Mark Adams (Klein’s own Board nominee) and Wasserman voted to remove Klein from his management positions at CTT. Klein subsequently alleged that the defendants tortiously interfered with Klein’s employment agreement and engaged in civil conspiracy. Both of these claims fail. To state a claim for tortious interference with his rights under the employment agreement, or a civil conspiracy claim based on that tortious interference, Klein must adequately allege that CTT breached his employment agreement. Because Klein does not allege facts to establish a contractual breach, both the claim for tortious interference and conspiracy lack a necessary predicate.

I. FACTUAL BACKGROUND The facts are drawn from the amended complaint1 and documents

incorporated therein.

A. CTT, Its Members, and Its Management Structure CTT is a Delaware limited liability company headquartered in Teaneck, New

Jersey. CTT packages and distributes pharmaceuticals, with a focus on “creating cost effective innovative medication delivery and packaging systems designed to improve patient medication adherence.”2 CTT has three classes of units—A, B, and C. Only Class A units carry voting rights. Klein owns 37,000 Class A units, which is a majority of the Class A units and CTT’s voting equity. Defendants Robert and Monica Breslow own 20,000 Class A units. Non-party Blue Valley, LLC (“Blue Valley”) owns 9,111 Class A units. Another non-party owns 8,000 Class A units.

The Breslows acquired their units for $12.5 million in June 2016. The plaintiffs allege that before the Breslows acquired a stake in CTT, they represented that they had “‘substantial’ connections to numerous dental clinics” and “that they would ‘bring’ 105 [such] . . . contacts to CTT.”3

1 C.A. No. 2017-0643-KSJM Docket (“Dkt.”) 14, Pls.’ Am. Compl. (“Amended Complaint” or “Am. Compl.”). 2 Id. ¶ 7.

3 Id. ¶¶ 13–14.

B. The Operating Agreement In connection with the Breslows’ investment, CTT’s members executed an

operating agreement in June 2016 (as amended in September 2016, the “Operating Agreement”).4 The Operating Agreement establishes a three-person Board of Managers (the “Board”) to manage CTT’s business and affairs. Of the three Board managers, Klein appoints two and the Breslows appoint one. At the time of the events prompting this litigation, the Board comprised Klein (Chairman), Adams (designated by Klein), and Wasserman (designated by the Breslows). Neither Wasserman nor Adams is currently a Board member.

The Operating Agreement permits the Board to appoint a CEO. Klein served as CEO and President pursuant to a June 2014 employment agreement that was amended at the time of the Breslows’ investment (the “Employment Agreement”). Klein served in those capacities until December 14, 2017, when Adams and Wasserman voted to remove Klein for cause.

The Operating Agreement conditions certain business decisions on Board approval and the affirmative vote of the Breslows’ Board designee. These decisions include making investments outside the approved Board policy, incurring capital

4 Am. Compl. Ex. A, Am. and Restated Operating Agreement of CTT (“Operating Agr.”).

expenditures over $250,000, and merging, selling, or liquidating all or a substantial portion of the company’s assets.

C. The Alleged Campaign to Force a Buy-Out Blue Valley acquired its units for $7 million in September 2016 at a

Free access — add to your briefcase to read the full text and ask questions with AI

John H. Klein v. Marc Wasserman, (Del. Ct. App. 2019).

John H. Klein v. Marc Wasserman (John H. Klein v. Marc Wasserman) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Aspen Advisors LLC v. United Artists Theatre Co.
843 A.2d 697 (Court of Chancery of Delaware, 2004)
Dunlap v. State Farm Fire & Casualty Co.
878 A.2d 434 (Supreme Court of Delaware, 2005)
Malpiede v. Townson
780 A.2d 1075 (Supreme Court of Delaware, 2001)
NACCO INDUSTRIES, INC. v. Applica Inc.
997 A.2d 1 (Court of Chancery of Delaware, 2009)
In Re General Motors (Hughes) Shareholder Litigation
897 A.2d 162 (Supreme Court of Delaware, 2006)
Orman v. Cullman
794 A.2d 5 (Court of Chancery of Delaware, 2002)
Kahn v. Lynch Communication Systems, Inc.
638 A.2d 1110 (Supreme Court of Delaware, 1994)
In Re Santa Fe Pacific Corp. Shareholder Litigation
669 A.2d 59 (Supreme Court of Delaware, 1995)
In Re Lukens Inc. Shareholders Litigation
757 A.2d 720 (Court of Chancery of Delaware, 1999)
Savor, Inc. v. FMR Corp.
812 A.2d 894 (Supreme Court of Delaware, 2002)
Diamond State Telephone Co. v. University of Delaware
269 A.2d 52 (Supreme Court of Delaware, 1970)
Nemec v. Shrader
991 A.2d 1120 (Supreme Court of Delaware, 2010)
Morgan v. Wells
80 A.2d 504 (Court of Chancery of Delaware, 1951)
In Re Cysive, Inc. Shareholders Litigation
836 A.2d 531 (Court of Chancery of Delaware, 2003)
Solomon v. Pathe Communications Corp.
672 A.2d 35 (Supreme Court of Delaware, 1996)
In Re Walt Disney Co. Derivative Litigation
906 A.2d 27 (Supreme Court of Delaware, 2006)
Irwin & Leighton, Inc. v. W.M. Anderson Co.
532 A.2d 983 (Court of Chancery of Delaware, 1987)
In Re Walt Disney Co. Derivative Litigation
907 A.2d 693 (Court of Chancery of Delaware, 2005)
Aspen Advisors LLC v. United Artists Theatre Co.
861 A.2d 1251 (Supreme Court of Delaware, 2004)